Gastroduodenal injury and repair: novel targets for therapeutic intervention
1Department of Surgery, Division of Surgical Sciences, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts, USA.
Purpose Of Review:
Although the mucosal barrier serves as a primary interface between the environment and host, little is understood about the repair of acute, superficial lesions or deeper, persistent lesions that if not healed, can be the site of increased permeability to luminal antigens, inflammation and/or neoplasia development.
Recent Findings:
Recent studies have focused on focal adhesion kinase, which regulates controlled matrix adhesion during restitution after superficial injury. Actin polymerization regulates cell migration and the importance of actin-related proteins was also highlighted. Work on SARS-CoV-2 infection lent important new insights on gastroduodenal mucosal injury in patients with Covid-19 infection and work done with organoids and intestine-on-a-chip contributed new understanding about how coronaviruses infect gastrointestinal tissues and its resulting barrier dysfunction. A novel risk stratification paradigm was proposed to assist with decision making about repeat endoscopy for patients with gastric or duodenal ulcers and new therapeutic options were studied for ulcer disease. Lastly, work to support the mechanism of metaplasia development after deep injury and parietal cell loss was provided using novel transgenic mouse models.
Summary:
Recent studies highlight novel molecular targets to promote mucosal healing after injury of the gastroduodenal mucosa.
Insights
Researchers are uncovering new molecular targets to improve healing of the gastroduodenal mucosa after injury. Understanding these mechanisms is key to preventing complications like inflammation and neoplasia.
Area of Science:
- Gastroenterology and Molecular Biology
- Mucosal Immunology
- Tissue Repair Mechanisms
Background:
- The gastroduodenal mucosal barrier is crucial for protecting the host from environmental factors.
- Impaired healing of mucosal lesions can lead to increased permeability, inflammation, and neoplasia.
- Understanding mucosal repair is essential for preventing gastrointestinal diseases.
Purpose of the Study:
- To review recent advancements in understanding gastroduodenal mucosal injury and repair.
- To highlight novel molecular targets and therapeutic strategies for promoting mucosal healing.
- To discuss new insights into coronavirus-induced gastroduodenal injury and ulcer disease management.
Main Methods:
- Review of recent scientific literature focusing on mucosal healing.
- Analysis of studies on focal adhesion kinase and actin polymerization in cell migration.
- Examination of research utilizing organoid and intestine-on-a-chip models.
- Inclusion of findings from studies on SARS-CoV-2 infection and gastroduodenal injury.
- Consideration of new therapeutic options and risk stratification paradigms for ulcer disease.
Main Results:
- Focal adhesion kinase and actin polymerization are key regulators of mucosal restitution and cell migration.
- SARS-CoV-2 infection causes gastroduodenal mucosal injury, with insights gained from organoid and in vitro models.
- Novel risk stratification tools and therapeutic strategies are emerging for managing gastric and duodenal ulcers.
- Transgenic mouse models are elucidating the mechanisms of metaplasia development following deep injury.
Conclusions:
- Recent research has identified novel molecular targets that can promote healing of the gastroduodenal mucosa.
- A deeper understanding of mucosal repair mechanisms is critical for addressing gastrointestinal pathology.
- Advances in research models and therapeutic approaches offer new hope for patients with mucosal injury and ulcer disease.
More Related Videos
11:48Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration
Published on: May 7, 2018
07:05Visualization of Neutrophil Extracellular Traps in Mesenteric Venules After Mesenteric Ischemia-Reperfusion Injury via Intravital Microscopy
Published on: September 27, 2024
Related Concept Videos
01:25Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
01:26Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
01:23Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
01:17Gastritis-II: Pathophysiology
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
01:30Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...